Patents by Inventor Paul Hafey

Paul Hafey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRANEXAMIC ACID ORAL SOLUTION
    Publication number: 20240024235
    Abstract: Methods and compositions are provided for treating a patient having a bleeding disorder during or after a dental procedure to reduce bleeding or need for factor replacement therapy. Aqueous pharmaceutical compositions are provided comprising tranexamic acid, sodium carboxymethyl cellulose, Tween® 20, and menthol wherein the composition exhibits good long term stability, little to no discoloration over time, and reduced bitterness compared to a control solution of tranexamic acid and water.
    Type: Application
    Filed: June 5, 2023
    Publication date: January 25, 2024
    Inventors: Mary Beth G. Erstad, Thomas Gerner Jacobsen, Mohammad Alkhalili, L. Diane Bruce, Paul Hafey
  • Tranexamic acid oral solution
    Patent number: 11666532
    Abstract: Methods and compositions are provided for treating a patient having a bleeding disorder during or after a dental procedure to reduce bleeding or need for factor replacement therapy. Aqueous pharmaceutical compositions are provided comprising tranexamic acid, sodium carboxymethyl cellulose, Tween® 20, and menthol wherein the composition exhibits good long term stability, little to no discoloration over time, and reduced bitterness compared to a control solution of tranexamic acid and water.
    Type: Grant
    Filed: January 9, 2019
    Date of Patent: June 6, 2023
    Assignee: Hyloris Developments SA
    Inventors: Mary Beth G. Erstad, Thomas Gerner Jacobsen, Mohammad Alkhalili, L. Diane Bruce, Paul Hafey
  • TRANEXAMIC ACID ORAL SOLUTION
    Publication number: 20190224121
    Abstract: Methods and compositions are provided for treating a patient having a bleeding disorder during or after a dental procedure to reduce bleeding or need for factor replacement therapy. Aqueous pharmaceutical compositions are provided comprising tranexamic acid, sodium carboxymethyl cellulose, Tween® 20, and menthol wherein the composition exhibits good long term stability, little to no discoloration over time, and reduced bitterness compared to a control solution of tranexamic acid and water.
    Type: Application
    Filed: January 9, 2019
    Publication date: July 25, 2019
    Inventors: Mary Beth G. Erstad, Thomas Gerner Jacobsen, Mohammad Alkhalili, L. Diane Bruce, Paul Hafey
  • Immediate release oral guaifenesin solution
    Patent number: 10105324
    Abstract: Disclosed is a method of treating or ameliorating a condition which can be treated or ameliorated by the administration of guaifenesin, which method comprises orally administering to a subject in need thereof an effective amount of an immediate release solution for oral administration of guaifenesin and at least one additional drug. In addition to water the solution comprises as solvents propylene glycol and glycerol in a concentration which significantly increases the bioavailability of guaifenesin in the human body.
    Type: Grant
    Filed: October 30, 2017
    Date of Patent: October 23, 2018
    Assignee: SOVEREIGN PHARMACEUTICALS, LLC
    Inventor: Paul Hafey
  • IMMEDIATE RELEASE ORAL GUAIFENESIN SOLUTION
    Publication number: 20180055786
    Abstract: Disclosed is a method of treating or ameliorating a condition which can be treated or ameliorated by the administration of guaifenesin, which method comprises orally administering to a subject in need thereof an effective amount of an an immediate release solution for oral administration of guaifenesin and at least one additional drug. In addition to water the solution comprises as solvents propylene glycol and glycerol in a concentration which significantly increases the bioavailability of guaifenesin in the human body.
    Type: Application
    Filed: October 30, 2017
    Publication date: March 1, 2018
    Inventor: Paul HAFEY
  • Immediate release oral guaifenesin solution
    Patent number: 9808431
    Abstract: Disclosed is an immediate release solution for oral administration of guaifenesin and at least one additional drug. In addition to water the solution comprises as solvents propylene glycol and glycerol in a concentration which significantly increases the bioavailability of guaifenesin in the human body.
    Type: Grant
    Filed: January 9, 2017
    Date of Patent: November 7, 2017
    Assignee: Sovereign Pharmaceuticals, LLC
    Inventor: Paul Hafey
  • IMMEDIATE RELEASE ORAL GUAIFENESIN SOLUTION
    Publication number: 20170135965
    Abstract: Disclosed is an immediate release solution for oral administration of guaifenesin and at least one additional drug. In addition to water the solution comprises as solvents propylene glycol and glycerol in a concentration which significantly increases the bioavailability of guaifenesin in the human body.
    Type: Application
    Filed: January 9, 2017
    Publication date: May 18, 2017
    Inventor: Paul HAFEY
  • Immediate release oral guaifenesin solution
    Patent number: 9549907
    Abstract: Disclosed is an immediate release solution for oral administration of guaifenesin and at least one additional drug. In addition to water the solution comprises as solvents propylene glycol and glycerol in a concentration which significantly increases the bioavailability of guaifenesin in the human body.
    Type: Grant
    Filed: November 13, 2015
    Date of Patent: January 24, 2017
    Assignee: SOVEREIGN PHARMACEUTICALS, LLC
    Inventor: Paul Hafey
  • Acid labile drug compositions
    Publication number: 20070036851
    Abstract: A composition and method of making a pharmaceutical dosage form containing an acid labile drug bound to an ion exchange resin is provided. The composition may be coated with a low acid content enteric coating. The binding of the acid labile drug to the exchange resin stabilizes the drug against acid degradation. The low acid content enteric coating controls the permeability of the enteric coating.
    Type: Application
    Filed: December 9, 2003
    Publication date: February 15, 2007
    Inventors: Deepak Thassu, Paul Hafey, Leo Magee
  • Multiple active drug resin conjugate
    Publication number: 20050142097
    Abstract: A combination pharmaceutical preparation including two different active drugs of the same ionic charge conjugated with a single resin particle, without one significantly displacing the other, and without retarding the initial availability of either active. Also, methods for the manufacture of a multiple active drug resin conjugate, and for the in vivo release of a combination of pharmaceutically active drugs from a multiple active drug resin conjugate.
    Type: Application
    Filed: December 29, 2003
    Publication date: June 30, 2005
    Inventors: Deepak Thassu, Paul Hafey